HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khoo, K.-H. Articles by Chatterjee, D. Search for Related Content PubMed PubMed Citation Articles by Khoo, K.-H. Articles by Chatterjee, D. Social Bookmarking                      What's this?

Volume 271, Number 45, Issue of November 8, 1996 pp. 28682-28690
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Truncated Structural Variants of Lipoarabinomannan in Ethambutol Drug-resistant Strains of Mycobacterium smegmatis
INHIBITION OF ARABINAN BIOSYNTHESIS BY ETHAMBUTOL

(Received for publication, June 7, 1996, and in revised form, August 19, 1996)

Kay-Hooi Khoo , Edward Douglas , Parastoo Azadi , Julia M. Inamine , Gurdyal S. Besra , Katarína Mikuová , Patrick J. Brennan and Delphi Chatterjee

From the Department of Microbiology, Colorado State University, Fort Collins, Colorado 80523 and the  Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602

The anti-tuberculosis drug, ethambutol (Emb), was previously shown to inhibit the synthesis of arabinans of both the cell wall arabinogalactan (AG) and lipoarabinomannan (LAM) of Mycobacterium tuberculosis and other mycobacteria. However, an Emb-resistant mutant, isolated by consecutive passage of the Mycobacterium smegmatis parent strain in media containing increasing concentrations of Emb, while synthesizing a normal version of AG, produced truncated forms of LAM when maintained on 10 µg/ml Emb (Mikuová, K., Slayden, R. A., Besra, G. S., and Brennan, P. J. (1995) Antimicrob. Agents Chemother. 39, 2482-2489). We have now isolated and characterized the truncated LAMs made by both the resistant mutant and a recombinant strain transfected with a plasmid containing the emb region from Mycobacterium avium which encodes for Emb resistance. By chemical analysis, endoarabinanase digestion, high pH anion exchange chromatography, and mass spectrometry analyses, truncation was demonstrated as primarily a consequence of selective and partial inhibition of the synthesis of the linear arabinan terminal motif, which constitutes a substantial portion of the arabinan termini in LAM but not of AG. However, at higher concentrations, Emb also affected the general biosynthesis of arabinan destined for both AG and LAM, resulting in severely truncated LAM as well as AG with a reduced Ara:Gal ratio. The results suggested that Emb exerts its antimycobacterial effect by inhibiting an array of arabinosyltransferases involved in the biosynthesis of arabinans unique to the mycobacterial cell wall. It was further concluded that the uniquely branched terminal Ara₆ motif common to both AG and LAM is an essential structural entity for a functional cell wall and, consequently, that the biosynthetic machinery responsible for its synthesis is the effective target of Emb in its role as a potent anti-tuberculosis drug.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Safi, B. Sayers, M. H. Hazbon, and D. Alland Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and Rifampin Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2027 - 2034. [Abstract] [Full Text] [PDF]

				J. Nigou, T. Vasselon, A. Ray, P. Constant, M. Gilleron, G. S. Besra, I. Sutcliffe, G. Tiraby, and G. Puzo Mannan Chain Length Controls Lipoglycans Signaling via and Binding to TLR2 J. Immunol., May 15, 2008; 180(10): 6696 - 6702. [Abstract] [Full Text] [PDF]

				E. A. Mahrous, R. B. Lee, and R. E. Lee A rapid approach to lipid profiling of mycobacteria using 2D HSQC NMR maps J. Lipid Res., February 1, 2008; 49(2): 455 - 463. [Abstract] [Full Text] [PDF]

				A. G. Amin, R. Goude, L. Shi, J. Zhang, D. Chatterjee, and T. Parish EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis Microbiology, January 1, 2008; 154(1): 240 - 248. [Abstract] [Full Text] [PDF]

				D. Kaur, M. R. McNeil, K.-H. Khoo, D. Chatterjee, D. C. Crick, M. Jackson, and P. J. Brennan New Insights into the Biosynthesis of Mycobacterial Lipomannan Arising from Deletion of a Conserved Gene J. Biol. Chem., September 14, 2007; 282(37): 27133 - 27140. [Abstract] [Full Text] [PDF]

				S. Berg, D. Kaur, M. Jackson, and P. J Brennan The glycosyltransferases of Mycobacterium tuberculosis--roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates Glycobiology, June 1, 2007; 17(6): 35R - 56R. [Abstract] [Full Text] [PDF]

				D. Kaur, S. Berg, P. Dinadayala, B. Gicquel, D. Chatterjee, M. R. McNeil, V. D. Vissa, D. C. Crick, M. Jackson, and P. J. Brennan Biosynthesis of mycobacterial lipoarabinomannan: Role of a branching mannosyltransferase PNAS, September 12, 2006; 103(37): 13664 - 13669. [Abstract] [Full Text] [PDF]

				P. Dinadayala, D. Kaur, S. Berg, A. G. Amin, V. D. Vissa, D. Chatterjee, P. J. Brennan, and D. C. Crick Genetic Basis for the Synthesis of the Immunomodulatory Mannose Caps of Lipoarabinomannan in Mycobacterium tuberculosis J. Biol. Chem., July 21, 2006; 281(29): 20027 - 20035. [Abstract] [Full Text] [PDF]

				L. Shi, S. Berg, A. Lee, J. S. Spencer, J. Zhang, V. Vissa, M. R. McNeil, K.-H. Khoo, and D. Chatterjee The Carboxy Terminus of EmbC from Mycobacterium smegmatis Mediates Chain Length Extension of the Arabinan in Lipoarabinomannan J. Biol. Chem., July 14, 2006; 281(28): 19512 - 19526. [Abstract] [Full Text] [PDF]

				X. Dong, S. Bhamidi, M. Scherman, Y. Xin, and M. R. McNeil Development of a Quantitative Assay for Mycobacterial Endogenous Arabinase and Ensuing Studies of Arabinase Levels and Arabinan Metabolism in Mycobacterium smegmatis Appl. Envir. Microbiol., April 1, 2006; 72(4): 2601 - 2605. [Abstract] [Full Text] [PDF]

				M. H. Hazbon, M. Bobadilla del Valle, M. I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Safi, H. Billman-Jacobe, C. Lavender, et al. Role of embB Codon 306 Mutations in Mycobacterium tuberculosis Revisited: a Novel Association with Broad Drug Resistance and IS6110 Clustering Rather than Ethambutol Resistance Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3794 - 3802. [Abstract] [Full Text] [PDF]

				A. Burguiere, P. G. Hitchen, L. G. Dover, A. Dell, and G. S. Besra Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole Microbiology, June 1, 2005; 151(6): 2087 - 2095. [Abstract] [Full Text] [PDF]

				T. Sengupta, M. Mukherjee, R. Das, A. Das, and H. K. Majumder Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II Nucleic Acids Res., April 28, 2005; 33(8): 2364 - 2373. [Abstract] [Full Text] [PDF]

				S. Berg, J. Starbuck, J. B. Torrelles, V. D. Vissa, D. C. Crick, D. Chatterjee, and P. J. Brennan Roles of Conserved Proline and Glycosyltransferase Motifs of EmbC in Biosynthesis of Lipoarabinomannan J. Biol. Chem., February 18, 2005; 280(7): 5651 - 5663. [Abstract] [Full Text] [PDF]

				R. E.B. Lee, W. Li, D. Chatterjee, and R. E. Lee Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed Glycobiology, February 1, 2005; 15(2): 139 - 151. [Abstract] [Full Text] [PDF]

				A. S. G. Lee, S. N. K. Othman, Y. M. Ho, and S. Y. Wong Novel Mutations within the embB Gene in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4447 - 4449. [Abstract] [Full Text] [PDF]

				H. I. M. Boshoff, T. G. Myers, B. R. Copp, M. R. McNeil, M. A. Wilson, and C. E. Barry III The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism: NOVEL INSIGHTS INTO DRUG MECHANISMS OF ACTION J. Biol. Chem., September 17, 2004; 279(38): 40174 - 40184. [Abstract] [Full Text] [PDF]

				S. V. Ramaswamy, A. G. Amin, S. Göksel, C. E. Stager, S.-J. Dou, H. El Sahly, S. L. Moghazeh, B. N. Kreiswirth, and J. M. Musser Molecular Genetic Analysis of Nucleotide Polymorphisms Associated with Ethambutol Resistance in Human Isolates of Mycobacterium tuberculosis Antimicrob. Agents Chemother., February 1, 2000; 44(2): 326 - 336. [Abstract] [Full Text]

				K.-H. Khoo, E. Jarboe, A. Barker, J. Torrelles, C.-W. Kuo, and D. Chatterjee Altered Expression Profile of the Surface Glycopeptidolipids in Drug-resistant Clinical Isolates of Mycobacterium avium Complex J. Biol. Chem., April 2, 1999; 274(14): 9778 - 9785. [Abstract] [Full Text] [PDF]

				A Telenti Genetics and pulmonary medicine bullet  5: Genetics of drug resistant tuberculosis Thorax, September 1, 1998; 53(9): 793 - 797. [Full Text]

				K.-H. Khoo, J.-B. Tang, and D. Chatterjee Variation in Mannose-capped Terminal Arabinan Motifs of Lipoarabinomannans from Clinical Isolates of Mycobacterium tuberculosis and Mycobacterium avium Complex J. Biol. Chem., February 2, 2001; 276(6): 3863 - 3871. [Abstract] [Full Text] [PDF]

				V. E. Escuyer, M.-A. Lety, J. B. Torrelles, K.-H. Khoo, J.-B. Tang, C. D. Rithner, C. Frehel, M. R. McNeil, P. J. Brennan, and D. Chatterjee The Role of the embA and embB Gene Products in the Biosynthesis of the Terminal Hexaarabinofuranosyl Motif of Mycobacterium smegmatis Arabinogalactan J. Biol. Chem., December 21, 2001; 276(52): 48854 - 48862. [Abstract] [Full Text] [PDF]